Literature DB >> 21911694

Rapidly progressive Alzheimer disease.

Christian Schmidt1, Martin Wolff, Michael Weitz, Thomas Bartlau, Carsten Korth, Inga Zerr.   

Abstract

Different rates of progression have been observed among patients with Alzheimer disease. Risk factors that accelerate deterioration have been identified and some are being discussed, such as genetics, comorbidity, and the early appearance of Alzheimer disease motor signs. Progressive forms of Alzheimer disease have been reported with rapid cognitive decline and disease duration of only a few years. This short review aims to provide an overview of the current knowledge of rapidly progressive Alzheimer disease. Furthermore, we suggest that rapid, in this context, should be defined as a Mini-Mental State Examination score decrease of 6 points per year.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911694     DOI: 10.1001/archneurol.2011.189

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  62 in total

Review 1.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

2.  Serial propagation of distinct strains of Aβ prions from Alzheimer's disease patients.

Authors:  Joel C Watts; Carlo Condello; Jan Stöhr; Abby Oehler; Joanne Lee; Stephen J DeArmond; Lars Lannfelt; Martin Ingelsson; Kurt Giles; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

3.  Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's disease.

Authors:  Jagan A Pillai; Aaron Bonner-Jackson; Esteban Walker; Lyla Mourany; Jeffrey L Cummings
Journal:  Dement Geriatr Cogn Disord       Date:  2014-06-04       Impact factor: 2.959

4.  Differences in Alzheimer disease clinical trial outcomes based on age of the participants.

Authors:  Lon S Schneider; Richard E Kennedy; Guoqiao Wang; Gary R Cutter
Journal:  Neurology       Date:  2015-02-13       Impact factor: 9.910

5.  Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.

Authors:  Mark L Cohen; Chae Kim; Tracy Haldiman; Mohamed ElHag; Prachi Mehndiratta; Termsarasab Pichet; Frances Lissemore; Michelle Shea; Yvonne Cohen; Wei Chen; Janis Blevins; Brian S Appleby; Krystyna Surewicz; Witold K Surewicz; Martha Sajatovic; Curtis Tatsuoka; Shulin Zhang; Ping Mayo; Mariusz Butkiewicz; Jonathan L Haines; Alan J Lerner; Jiri G Safar
Journal:  Brain       Date:  2015-02-15       Impact factor: 13.501

6.  A multivariate model of time to conversion from mild cognitive impairment to Alzheimer's disease.

Authors:  María Eugenia López; Agustín Turrero; Pablo Cuesta; Inmaculada Concepción Rodríguez-Rojo; Ana Barabash; Alberto Marcos; Fernando Maestú; Alberto Fernández
Journal:  Geroscience       Date:  2020-09-04       Impact factor: 7.713

7.  Exploratory analysis of seven Alzheimer's disease genes: disease progression.

Authors:  Agustín Ruiz; Isabel Hernández; Maiteé Ronsende-Roca; Antonio González-Pérez; Emma Rodriguez-Noriega; Reposo Ramírez-Lorca; Ana Mauleón; Concha Moreno-Rey; Lucie Boswell; Larry Tune; Sergi Valero; Montserrat Alegret; Javier Gayán; James T Becker; Luis Miguel Real; Lluís Tárraga; Clive Ballard; Michael Terrin; Stephanie Sherman; Haydeh Payami; Oscar L López; Jacobo E Mintzer; Mercè Boada
Journal:  Neurobiol Aging       Date:  2012-10-01       Impact factor: 4.673

8.  Incidence and impact of subclinical epileptiform activity in Alzheimer's disease.

Authors:  Keith A Vossel; Kamalini G Ranasinghe; Alexander J Beagle; Danielle Mizuiri; Susanne M Honma; Anne F Dowling; Sonja M Darwish; Victoria Van Berlo; Deborah E Barnes; Mary Mantle; Anna M Karydas; Giovanni Coppola; Erik D Roberson; Bruce L Miller; Paul A Garcia; Heidi E Kirsch; Lennart Mucke; Srikantan S Nagarajan
Journal:  Ann Neurol       Date:  2016-11-07       Impact factor: 10.422

9.  Plasma prion protein concentration and progression of Alzheimer disease.

Authors:  Christian Schmidt; Harry Becker; Christoph Peter; Katharina Lange; Tim Friede; Inga Zerr
Journal:  Prion       Date:  2014-02-18       Impact factor: 3.931

10.  A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD.

Authors:  Swati Haldar; 'alim J Beveridge; Joseph Wong; Ajay Singh; Daniela Galimberti; Barbara Borroni; Xiongwei Zhu; Janis Blevins; Justin Greenlee; George Perry; Chinmay K Mukhopadhyay; Christine Schmotzer; Neena Singh
Journal:  Antioxid Redox Signal       Date:  2013-04-16       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.